Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q2 2024 Earnings Call Transcript August 14, 2024
Verrica Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.37, expectations were $-0.43.
Operator: Good morning, and welcome to the Verrica Pharmaceuticals Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s remarks, there will be a question-and-answer session. [Operator Instructions] Please note today’s call...
